本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

AIM ImmunoTech Inc.

1.46
+0.04803.40%
成交量:1.71万
成交额:2.44万
市值:403.02万
市盈率:-0.06
高:1.46
开:1.40
低:1.39
收:1.41
52周最高:20.35
52周最低:1.39
股本:276.42万
流通股本:264.52万
量比:0.52
换手率:0.65%
股息:- -
股息率:- -
每股收益(TTM):-24.1217
每股收益(LYR):-30.9192
净资产收益率:-3138.91%
总资产收益率:-104.62%
市净率:-0.62
市盈率(LYR):-0.05

数据加载中...

2024/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/31

SEC问询函

Form CORRESP - Correspondence
2024/10/01

重要事件披露

Form 8-K - Current report
2024/09/12

重要事件披露

Form 8-K - Current report
2024/09/11

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/03

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/14

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/01

重要事件披露

Form 8-K - Current report
2024/07/30

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/23

SEC问询函

Form CORRESP - Correspondence
2024/07/20

SEC问询函

Form CORRESP - Correspondence
2024/07/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/15

重要事件披露

Form 8-K - Current report
2024/07/12

SEC问询函

Form CORRESP - Correspondence
2024/07/11

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/07/01

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/03

重要事件披露

Form 8-K - Current report
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]